Loading Events

Cardiovascular Health in the Time of COVID-19

Springer Nature | Kathrin de la Rosa, Holger Gerhardt, Michael Potente, Leif Erik Sander, Birgit Sawitzki, Vesna Todorovic

Springer Nature, in collaboration with the Max-Delbrück-Centrum für Molekulare Medizin, the Berlin Institute of Health and Charité – Universitätsmedizin Berlin, presents a panel discussion entitled “Cardiovascular health and COVID-19”.

COVID-19, caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic that has affected the lives of the entire human population. The panel, composed of Berlin-based renowned experts in basic, translational and clinical science focused on cardiovascular disease and immunology, will discuss three key aspects:

how pre-existing cardiovascular condition is associated with worse outcomes and increased risk of death in patients with COVID-19,
how COVID-19 itself can induce cardiovascular disease, such as venous thromboembolism, high blood pressure, acute coronary syndrome, myocardial injury, and arrhythmia, and
how we can minimize all these risks by vaccination.

Panelists:

Professor Kathrin de la Rosa, Berlin Institute of Health (BIH) at Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Professor Holger Gerhardt, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH) at Charité and DZHK (German Center for Cardiovascular Research) Partner Site Berlin
Professor Michael Potente, Berlin Institute of Health (BIH) at Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Professor Leif Erik Sander, Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin
Professor Birgit Sawitzki, Berlin Institute of Health (BIH) at Charité and Institute of Medical Immunology, Charité – Universitätsmedizin Berlin

Moderation: Dr. Vesna Todorovic, Chief Editor, Nature Cardiovascular Research

The panel discussion will start at 6pm Berlin time, will last 1 hour and will be followed by a Q&A session with the panelists and the audience.  The event will end at 8pm Berlin time.

 

PUBLIC ONLINE DISCUSSION.

The event has been moved from 8 to 5 November. More information will follow soon.

Return to overview

Kathrin de la Rosa

Max-Delbrück-Centrum für Molekulare Medizin

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH) at Charité

Holger Gerhardt

MAX-DELBRÜCK-CENTER FOR MOLECULAR MEDICINE

Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH) at Charité and DZHK (German Center for Cardiovascular Research) Partner Site Berlin

Michael Potente

Berlin Institute of Health (BIH)

Berlin Institute of Health (BIH) at Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

Leif Erik Sander

Charité – Universitätsmedizin Berlin

Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin

Birgit Sawitzki

Charité – Universitätsmedizin Berlin

Berlin Institute of Health (BIH) at Charité and Institute of Medical Immunology, Charité – Universitätsmedizin Berlin

Vesna Todorovic

Springer Nature

Nature Cardiovascular Research

See all speakers
Next events
Featured

The Future of Digital Health

Tohoku University | Ryoichi Nagatomi, Giampaolo Pileggi, Iwao Waga, Sylvia Thun
Read more

More Events

All Events